First diet | Vegan supplemented | With protein- free food | Other | All cases | p Among groups |
---|---|---|---|---|---|
n | 35 | 59 | 6 | 100 | Â |
Males/Females (%) | 29 (82.9%) 6 (17.1%) | 38 (64.4%) 21 (35.6%) | 5 (83.3%) 1 (16.7%) | 72 (72.0%) 28 (28.0%) | 0.128 |
Age at start of the diet median (min-max) | 71 | 78 | 70 | 74 | 0.003 |
Charlson index median (min max) | 9 (6–12) | 9 (5–12) | 8 (2–11) | 9 (2–12) | 0.794 |
Charlson > =7 (%) | 30 (85.7%) | 53 (89.8%) | 4 (66.7%) | 87 (87.0%) | 0.264 |
Charlson > =10 (%) | 9 (25.7%) | 19 (32.2%) | 2 (33.3%) | 30 (30.0%) | 0.789 |
Diabetes (%) | 17 (48.6%) | 30 (50.8%) | 3 (50.0%) | 50 (50.0%) | 0.977 |
Cardiopathy (%) | 27 (77.1%) | 49 (83.1%) | 4 (66.7%) | 80 (80.0%) | 0.552 |
Neoplasia (%) | 9 (25.7%) | 12 (20.3%) | 1 (16.7%) | 22 (22.0%) | 0.788 |
s Creatinine (mg/dL) median, (min-max) | 3.0 1.6–5 | 2.5 1.1–5.9 | 3.65 2.6–4.3 | 2.90 1.1–5.9 | 0.002 |
eGFR-EPI (mL/min) median, (min-max) | 18.9 10.9–44.5 | 20.8 7.7–73.1 | 16.0 10.3–17.7 | 20.0 7.7–73.1 | 0.022 |
Proteinuria (g/day) median, (min-max) | 0.5 0.1–4.6 | 0.2 0.1–6.3 | 0.2 0.1–1.0 | 0.35 0.1–6.3 | 0.111 |
Proteinuria > = 1 g/day (%) | 12 (34.3%) | 13 (22.8%) | 1 (16.7%) | 26 (26.0%) | 0.410 |
Glomerulonephritis-systemic disease (%) | 3 (8.6%) | 1 (1.7%) | 0 | 4 (4%) | 0.226 |
Nephroangiosclerosis and/or diabetes (%) | 30 (85.7%) | 52 (88.1%) | 4 (66.7%) | 86 (86%) | 0.352 |
Main causes of death | |||||
 Cardiovascular (%) | 16 (45.7%) | 29 (49.1%) | 2 (33.3%) | 47 (47%) | 0.590 |
 Neoplasia (%) | 4 (11.4%) | 3 (5.1%) | 1 (16.7%) | 8 (8%) | |
 Lung disease (%) | 1 (2.8%) | 4 (6.7%) | 0 | 5 (5%) | |
 Infection (%) | 4 (11.4%) | 5 (8.5%) | 0 | 9 (9%) | |
 Other (%) | 6 (17.1%) | 5 (8.5%) | 2 (33.3%) | 13 (13%) | |
 Unknown (%) | 4 (11.4%) | 13 (22.1%) | 1 (16.7%) | 18 (18%) |